Inventor · disambiguated record
Stephen W. Byers
Also filed as: BYERS STEPHEN · BYERS STEPHEN W
14 granted patents·9 pending applications·162 citations·filing 1999–2021
91Inventor score
Top patents by PatentIndex Score
23 records- 0188US6682901B2Methods for diagnosing and evaluating cancerADHEREX TECHNOLOGIES INC·Filed 1999·Granted Jan 27, 2004·63 cites·2 claims
- 0282US6677116B1Methods for treating cancer by modulating β-catenin mediated gene expressionADHEREX TECHNOLOGIES INC·Filed 2000·Granted Jan 13, 2004·14 cites·13 claims
- 0376US6433149B1Compounds and methods for inhibiting cancer metastasisADHEREX TECHNOLOGIES INC·Filed 1999·Granted Aug 13, 2002·33 cites·10 claims
- 0475US6303576B1Compounds and methods for modulating β-catenin mediated gene expressionADHEREX TECHNOLOGIES INC·Filed 1999·Granted Oct 16, 2001·30 cites·25 claims
- 0570US9889131B2Cadherin-11 inhibitors and methods of use thereofUNIV GEORGETOWN·Filed 2016·Granted Feb 13, 2018·1 cites·11 claims
- 0670US8802687B2Cadherin-11 inhibitors and methods of use thereofBYERS STEPHEN W·Filed 2010·Granted Aug 12, 2014·2 cites·3 claims
- 0769US9284368B2Substituted pyrazines as cadherin-11 inhibitorsUNIV GEORGETOWN·Filed 2014·Granted Mar 15, 2016·1 cites·8 claims
- 0866US2004248220A1Methods for diagnosing and evaluating cancerADHEREX TECHNOLOGIES INC·Filed 2004·Application pending·0 cites
- 0963US6706685B1Compounds and methods for stimulating β-catenin mediated gene expression and differentiationADHEREX TECHNOLOGIES INC·Filed 2000·Granted Mar 16, 2004·1 cites·11 claims
- 1062US7481999B2Compounds and methods for modulating OB-cadherin-mediated functionADHEREX TECHNOLOGIES INC·Filed 2004·Granted Jan 27, 2009·0 cites·3 claims
- 1157US2005203025A1Compounds and methods for modulating nonclassical cadherin-mediated functionsADHEREX TECHNOLOGIES INC·Filed 2004·Application pending·0 cites
- 1255US2023210849A1Cadherin-11 inhibitor formulation and its uses in immunotherapyUNIV GEORGETOWN·Filed 2021·Application pending·0 cites
- 1355US2005222037A1Compounds and methods for modulating VE-cadherin-mediated functionADHEREX TECHNOLOGIES INC·Filed 2004·Application pending·0 cites
- 1453US2004254099A1Compounds and methods for modulating beta-catenin mediated gene expressionADHEREX TECHNOLOGIES INC·Filed 2003·Application pending·0 cites
- 1551US2004142854A1Compounds and methods for stimulating beta-catenin mediated gene expression and differentiationADHEREX TECHNOLOGIES INC·Filed 2003·Application pending·0 cites
- 1650US6680175B2Methods for diagnosing and evaluating cancerADHEREX TECHNOLOGIES INC·Filed 1999·Granted Jan 20, 2004·10 cites·6 claims
- 1747US11179395B2Treating melanoma with mebendazole and a mitogen-activated kinase inhibitorUNIV GEORGETOWN·Filed 2018·Granted Nov 23, 2021·0 cites·4 claims
- 1847US10916331B2Predicting drug-target interactions and uses for drug repositioning and repurposingUNIV GEORGETOWN·Filed 2016·Granted Feb 9, 2021·0 cites·17 claims
- 1947US2003096746A1Compounds and methods for inhibiting cancer metastasisADHEREX TECHNOLOGIES INC·Filed 2002·Application pending·0 cites
- 2046US6593297B2Compounds and methods for inhibiting cancer metastasisADHEREX TECHNOLOGIES INC·Filed 1999·Granted Jul 15, 2003·7 cites·14 claims
- 2144US2015324546A1Method for predicting drug-target interactions and uses for drug repositioningUNIV GEORGETOWN·Filed 2013·Application pending·0 cites
- 2243US9199918B2Small molecule inhibitors of AGBL2BYERS STEPHEN W·Filed 2012·Granted Dec 1, 2015·0 cites·6 claims
- 2333US2004248219A1Methods for diagnosing and evaluating cancerADHEREX TECHNOLOGIES INC·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stephen W. Byers files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →